Certified Advisory Corp’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $638K | Buy |
1,762
+349
| +25% | +$119K | 0.05% | 204 |
|
|
2026
Q1 | $497K | Sell |
1,413
-134
| -9% | -$47.8K | 0.04% | 212 |
|
|
2025
Q4 | $506K | Sell |
1,547
-19
| -1% | -$6.03K | 0.05% | 206 |
|
|
2025
Q3 | $442K | Buy |
1,566
+9
| +0.6% | +$2.61K | 0.04% | 219 |
|
|
2025
Q2 | $435K | Buy |
1,557
+120
| +8% | +$34K | 0.05% | 214 |
|
|
2025
Q1 | $448K | Sell |
1,437
-53
| -4% | -$15.7K | 0.05% | 202 |
|
|
2024
Q4 | $388K | Buy |
1,490
+20
| +1% | +$5.93K | 0.04% | 223 |
|
|
2024
Q3 | $474K | Buy |
1,470
+10
| +0.7% | +$3.27K | 0.05% | 198 |
|
|
2024
Q2 | $456K | Buy |
1,460
+201
| +16% | +$59K | 0.06% | 191 |
|
|
2024
Q1 | $358K | Buy |
1,259
+15
| +1% | +$4.39K | 0.05% | 204 |
|
|
2023
Q4 | $358K | Sell |
1,244
-6,660
| -84% | -$1.81M | 0.05% | 195 |
|
|
2023
Q3 | $341K | Buy |
7,904
+6,628
| +519% | +$1.65M | 0.06% | 175 |
|
|
2023
Q2 | $283K | Sell |
1,276
-31
| -2% | -$7.19K | 0.05% | 190 |
|
|
2023
Q1 | $316K | Sell |
1,307
-940
| -42% | -$231K | 0.06% | 189 |
|
|
2022
Q4 | $590K | Buy |
2,247
+31
| +1% | +$8.31K | 0.12% | 149 |
|
|
2022
Q3 | $500K | Buy |
2,216
+889
| +67% | +$215K | 0.11% | 154 |
|
|
2022
Q2 | $323K | Buy |
1,327
+37
| +3% | +$9.07K | 0.07% | 171 |
|
|
2022
Q1 | $312K | Hold |
1,290
| – | – | 0.07% | 184 |
|
|
2021
Q4 | $290K | Hold |
1,290
| – | – | 0.06% | 189 |
|
|
2021
Q3 | $274K | Buy |
1,290
+61
| +5% | +$14K | 0.07% | 183 |
|
|
2021
Q2 | $300K | Hold |
1,229
| – | – | 0.08% | 179 |
|
|
2021
Q1 | $306K | Buy |
+1,229
| New | +$293K | 0.08% | 167 |
|
|
2020
Q2 | $285K | Buy |
1,208
+200
| +20% | +$45.6K | 0.09% | 159 |
|
|
2020
Q1 | $205K | Hold |
1,008
| – | – | 0.08% | 162 |
|
|
2019
Q4 | $243K | Hold |
1,008
| – | – | 0.08% | 171 |
|
|
2019
Q3 | $196K | Hold |
1,008
| – | – | 0.07% | 183 |
|
|
2019
Q2 | $185K | Sell |
1,008
-90
| -8% | -$16.1K | 0.07% | 180 |
|
|
2019
Q1 | $209K | Hold |
1,098
| – | – | 0.09% | 156 |
|
|
2018
Q4 | $214K | Hold |
1,098
| – | – | 0.11% | 141 |
|
|
2018
Q3 | $228K | Hold |
1,098
| – | – | 0.11% | 143 |
|
|
2018
Q2 | $202K | Sell |
1,098
-29
| -3% | -$5.13K | 0.11% | 140 |
|
|
2018
Q1 | $191K | Buy |
1,127
+1,001
| +794% | +$184K | 0.11% | 143 |
|
|
2017
Q4 | $21K | Buy |
+126
| New | +$22.3K | 0.02% | 358 |
|
Other funds holding AMGN
FFM
SP
BCWM
SMDAM
Certified Advisory Corp's AMGN Position: Q2 2026 in Review
Certified Advisory Corp increased its Amgen (AMGN) stake by 25% in Q2 2026, buying an estimated $119K and bringing the position to 1,762 shares worth $638K. The position accounts for 0.05% of the portfolio, ranked #204.
Certified Advisory Corp first reported a position in AMGN in Q4 2017 and has held it in 33 quarters since. 1,151 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Certified Advisory Corp held 1,762 shares of Amgen worth $638K as of Q2 2026.
- Certified Advisory Corp bought 349 Amgen shares in Q2 2026, an estimated $119K.
- Amgen made up 0.05% of Certified Advisory Corp's portfolio in Q2 2026, its #204 holding.
- Certified Advisory Corp first reported a position in Amgen in Q4 2017 and has held it in 33 quarters since.
- 1,151 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Certified Advisory Corp's 13F filing for Q2 2026, filed 16 Jul 2026.